As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
19 Analysts have issued a SCHOTT Pharma forecast:
19 Analysts have issued a SCHOTT Pharma forecast:
Mar '25 |
+/-
%
|
||
Revenue | 973 973 |
29%
29%
|
|
Gross Profit | 320 320 |
33%
33%
|
|
EBITDA | 257 257 |
22%
22%
|
EBIT (Operating Income) EBIT | 184 184 |
27%
27%
|
Net Profit | 148 148 |
33%
33%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Head office | Germany |
CEO | Andreas Reisse |
Employees | 4,681 |
Founded | 2022 |
Website | www.schott-pharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.